Assenagon Asset Management S.A. Solid Biosciences Inc. Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$0.74 - $1.79 $19,160 - $46,348	-25,893 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$1.69 - $2.46 $43,759 - $63,696	25,893 New	25,893 $45,000
Q3 2021 Oct 19, 2021	SELL	$2.38 - $3.77 $101,388 - $160,602	-42,600 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$3.49 - $5.51 $148,674 - $234,726	42,600 New	42,600 $156,000
Q3 2019 Oct 16, 2019	SELL	$4.33 - $11.64 $1.3 Million - $3.49 Million	-300,028 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$4.6 - $10.13 $1.38 Million - $3.04 Million	300,028 New	300,028 $1.73 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.